CASI Pharmaceuticals CASIF Ratios (2021-2025)

OTC CASIF
$0.13 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 58.77%58.75%58.42%107.10%59.53%59.41%58.72%59.05%52.98%51.95%51.91%24.17%58.00%49.29%22.96%51.14%
EBT Margin (Quarter) -77.09%-74.75%-55.98%-979.35%-86.41%-95.16%-57.65%-941.34%-273.48%-217.49%-106.78%-97.46%-165.10%-265.39%-346.89%-1,073.77%
EBIT Margin (Quarter) -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
EBITDA Margin (Quarter) -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
Operating Margin (Quarter) -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
Net Margin (Quarter) -83.88%-83.35%-64.95%-1,049.86%-96.54%-102.11%-66.35%-954.51%-273.48%-217.49%-106.78%-97.46%-165.10%-265.39%-346.89%-1,073.77%
Efficiency
Inventory Average (Quarter) 7,946.21M7,314.71M2,079.13M2,078.20M3.00M2.10M
Assets Average (Quarter) 66.64M29.03M31.83M58.65M26.86M15.62M27.83M25.06M
Invested Capital (Quarter) 18.39M19.19M
Asset Utilization Ratio (Quarter) 0.430.800.690.491.172.020.960.83
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.18-0.06-55.42-217.45
Debt Ratio (Quarter) 0.100.12251.040.320.36M0.340.75
Times Interest Earned (Quarter) -0.18-0.06-55.42-217.45
Valuation
Enterprise Value (Quarter) -48.57M-26.22M1,765.98M-29.09M-12.20M-0.01M-16.54M-13.47M-0.01M-6.74M-4.68M-5.60M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%-0.01%-0.10%-0.01%-0.01%-0.01%-0.09%-0.03%-0.02%-0.01%-0.01%-0.02%-0.03%-0.03%-0.11%
Return on Capital Employed (Quarter) -47.03%0.28%-178.53%0.12%193.90%389.12%444.36%
Return on Assets (Quarter) -0.01%-0.03%-0.03%-0.01%-0.02%-0.03%-0.02%-0.04%